remdesivir
The Latest
-
India Stops Export Of Remdesivir Until COVID Situation Improves Across Country
The generic drug named remdesivir is considered vital in the fight against COVID-19. The generic drug named remdesivir is considered vital in the fight against COVID-19. -
WHO Recommends Against Use Of Remdesivir For Treating COVID-19
The World Health Organization said that there was insufficient evidence to recommend remdesivir for treating COVID-19 patients. The World Health Organization said that there was insufficient evidence to recommend remdesivir for treating COVID-19 patients. -
FDA Approval Of Eli Lilly COVID Treatment To Boost Share Price Friday
The combination treatment was granted EUA based on a randomized double-blind clinical test. The combination treatment was granted EUA based on a randomized double-blind clinical test. -
U.S. Researchers Say Eli Lilly Experimental COVID Treatment Ineffective
The National Institute of Allergy and Infectious Diseases says there are no safety issues but a very low chance the treatment will be useful. The National Institute of Allergy and Infectious Diseases says there are no safety issues but a very low chance the treatment will be useful. -
Gilead Sciences’ Remdesivir Is First FDA-Approved COVID-19 Treatment
One expert says the drug shows “modest" benefits but isn’t “a remarkable improvement." One expert says the drug shows “modest" benefits but isn’t “a remarkable improvement." -
Remdesivir A Major Flop In Global Vaccine Test Made By WHO
But Gilead Sciences said the results did not mean the vaccine is useless. But Gilead Sciences said the results did not mean the vaccine is useless. -
Eli Lilly COVID Vaccine Test Halted On Safety Issues
Lilly research director Mathai Mammen said it was a "temporary pause" that may not have any connections to their vaccine. Lilly research director Mathai Mammen said it was a "temporary pause" that may not have any connections to their vaccine. -
Gilead Sciences' Remdesivir Speeds COVID Recovery Time: Study
Remdesivir has been granted emergency use authorization by the U.S. Food and Drug Administration for treating patients hospitalized for the virus. Remdesivir has been granted emergency use authorization by the U.S. Food and Drug Administration for treating patients hospitalized for the virus. -
Trump Also Given Experimental Drug Remdesivir To Help Shorten His Illness From COVID
Remdesivir costs around $520 per shot, based on the price announced by its developer, Gilead Sciences in June. Remdesivir costs around $520 per shot, based on the price announced by its developer, Gilead Sciences in June. -
Eli Lilly, Gilead Sciences' Drugs Help Reduce COVID-19 Patients' Hospital Stays
Eli Lilly, spurred by Olumiant's COVID impressive test results, seeks emergency FDA approval. Eli Lilly, spurred by Olumiant's COVID impressive test results, seeks emergency FDA approval.